| 000 | 00937 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250511205833.0 | ||
| 264 | 0 | _c19911217 | |
| 008 | 199112s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.303.6806.855-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDalton, K | |
| 245 | 0 | 0 |
_aDMPA and bone density. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cOct 1991 |
||
| 300 |
_a855 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aContraceptive Agents, Female _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone _xadverse effects |
| 650 | 0 | 4 | _aMedroxyprogesterone Acetate |
| 700 | 1 | _aDalton, M J | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 303 _gno. 6806 _gp. 855 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.303.6806.855-b _zAvailable from publisher's website |
| 999 |
_c1840495 _d1840495 |
||